GSK-2801

N/A

Report date: 2025/03/20 10:15:20
NME

Base Information

Drug NameGSK-2801
Drug Alias NameGSK-2801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain adjacent to zinc finger domain protein 2B inhibitorsBromodomain adjacent to zinc finger domain protein 2A inhibitors
TargetsBromodomain adjacent to zinc finger domain protein 2BBromodomain adjacent to zinc finger domain protein 2A
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A